AbbVie is a North Chicago-based biopharmaceutical company that develops and sells medicines across various therapeutic areas, employing 50,000 staff since its IPO in January 2013. Key products include Humira, Botox, and NX-13 for ulcerative colitis.
Kevin K Buckbee sold 18,944 shares of ABBV on 26 February at $203.41 per share, worth a total of $3.9M. They now own 12,646 ABBV shares, or a 62% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
